Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local analgesic effect of CAM2028 in radiation-induced oral mucositis
2007-000163-26Phase 2Completed
- Sponsor
- Camurus
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CAM2028 in oral mucositis (OM) and head and neck cancer (HNC) (2 arms), sponsored by Camurus. Primary endpoint: Pain intensity difference over 6 hours. Started Feb 2007; status: completed.
02
Drugs
CAM2028
03
Conditions
oral mucositis (OM)head and neck cancer (HNC)
Beyond the preview
Go deeper on 2007-000163-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000163-26.